As of 2025-12-22, the Relative Valuation of bluebird bio Inc (BLUE) is (364.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.97 USD, the upside of bluebird bio Inc based on Relative Valuation is -7436.5%.
The range of the Relative Valuation is (361.97) - (423.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 20.7x | 17.8x |
| Forward P/E multiples | 15.3x - 20.8x | 17.9x |
| Fair Price | (361.97) - (423.25) | (364.62) |
| Upside | -7383.1% - -8616.1% | -7436.5% |
| Date | P/E |